e-learning
resources
ERJ
Supplements
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparative mycobacterial genomics as a tool for drug target and antigen discovery
Cole S.T.
Source:
Eur Respir J 2002; 20: 78S-86S
Journal Issue:
July 2002 - Suppl. 36
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Cole S.T.. Comparative mycobacterial genomics as a tool for drug target and antigen discovery. Eur Respir J 2002; 20: 78S-86S
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Omics and single molecule detection: the future of TB diagnostics
Source: Eur Respir Mon 2012; 58: 144-153
Year: 2012
The genetics of asthma and the promise of genomics-guided drug discovery
Source: Virtual Congress 2020 – Reducing the burden of asthma
Year: 2020
High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
High-resolution quantitative proteomics applied to the discovery of biomarkers of innate immune response in tuberculosis.
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Source: Eur Respir J 2009; 33: 489-506
Year: 2009
Towards new antituberculotic targets: biochemical characterisation of mycobacterial RNase E/G
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007
Quantitative membrane proteomics reveals new functions ofCD13 in mycobacterium tuberculosis infection
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
From genetical genomics to system genetics: application in asthma/COPD
Source: ERS Research Seminar 2015
Year: 2015
Genetics, genomics and a systems approach to asthma
Source: Annual Congress 2008 - “Omics” and systems biology: the promise of future disease understanding
Year: 2008
Scene-setting: why do we need genomics and proteomics to understand pathology?
Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease
Year: 2004
Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease
Source: International Congress 2017 – Update on TB: latest news
Year: 2017
An integrative genomics approach identifies new asthma pathways related to air pollution exposure
Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Year: 2015
A fully molecular drug sensitivity pattern for M.tuberculosis complex: what is available today and what is in the pipeline
Source: International Congress 2017 – How to manage difficult tuberculosis cases: diagnosis and treatment
Year: 2017
Molecular epidemiology of tuberculosis
Source: Eur Respir J 2002; 20: 54S-65S
Year: 2002
Genomics-based identification of targets in pathogenic bacteria for potential therapeutic use
Source: Annual Congress 2004 - Novel approaches to the treatment of pneumonia
Year: 2004
Accelerating tuberculosis elimination in low-incidence settings: the role of genomics
Source: Eur Respir J 2015; 46: 1840-1841
Year: 2015
Accelerating tuberculosis elimination in low-incidence settings: the role of genomics
Source: Eur Respir J 2015; 46: 1841-1843
Year: 2015
Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
Source: Eur Respir J 2013; 42: 802-825
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept